Zacks Research Has Positive Outlook for TEVA Q2 Earnings
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Equities researchers at Zacks Research increased their Q2 2025 earnings per share (EPS) estimates for shares of Teva Pharmaceutical Industries in a research note issued to investors on Wednesday, May 28th. Zacks Research analyst R. Department now anticipates that the company will earn $0.62 per share […]
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Equities researchers at Zacks Research increased their Q2 2025 earnings per share (EPS) estimates for shares of Teva Pharmaceutical Industries in a research note issued to investors on Wednesday, May 28th. Zacks Research analyst R. Department now anticipates that the company will earn $0.62 per share […]
